Investors in MGNX have the chance to take the lead in a securities fraud lawsuit with the Schall Law Firm.
Investors of MGNX have the chance to take on a leading role in a securities fraud lawsuit against MacroGenics, Inc. with the Schall Law Firm.
MGNX
MacroGenics has revealed the data presentation from Phase 2 of the TAMARACK study at the ESMO Congress in 2024.
MacroGenics will be hosting an investor call to discuss the important data shared at ESMO on September 16, 2024, at 8:00 a.m. ETROCKVILLE, MD. The event will focus on reviewing key findings from the presentation.
Former Louisiana Attorney General Kahn Swick & Foti, LLC are reminding investors who have suffered losses over $100,000 about the upcoming deadline for the lead plaintiff in the class action lawsuit against MacroGenics, Inc.
Kahn Swick & Foti, LLC (KSF) and its partner Charles C. Foti, Jr., are notifying investors that they must submit lead plaintiff applications by September 24, 2024.
Shareholders of MacroGenics, Inc. are urged to contact Levi & Korsinsky LLP before September 24, 2024 to discuss their rights regarding MGNX.
Read More: https://www.tipranks.com/news/class-action/shareholders-of-macrogenics-inc-should-contact-levi-korsinsky-llp-before-september-24-2024-to-discuss-your-rights-mgnx?utm_source=alphanewsstream.com&utm_medium=referral
SHAREHOLDER ALERT: Pomerantz Law Firm is examining allegations on behalf of MacroGenics, Inc. investors.
Pomerantz Law Firm is looking into allegations on behalf of MacroGenics, Inc. investors.
